VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650673
Sex: F
Age:
State: ID

Vax Date: 03/27/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Erythromelalgia in toes worst ever ongoing flare since the first vaccine dose; EM presents in my toes so seems related to COVID toes; Erythromelalgia in toes worst ever ongoing flare since the first vaccine dose; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 27Mar2021(at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history included erythromelalgia and was ongoing. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 01Apr2021, the patient experienced " have had erythromelalgia for a few years and have had the worst ever ongoing flare since the first vaccine dose". EM presents in the toes so seems to related to "COVID toes". The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events " have had erythromelalgia for a few years and have had the worst ever ongoing flare since the first vaccine dose". EM presents in the toes so seems to related to "COVID toes" were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Erythromelalgia (Have had erythromelalgia for a few years. EM presents in toes.)

ID: 1650674
Sex: M
Age:
State: IN

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Itching skin arms legs back; Burning skin arms legs back; Stinging skin arms legs back; This is a spontaneous report received from a contactable consumer, the parent. A 79-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included heart (heart disorder) and kidneys (kidney disorder). The patient had unspecified allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was unknown whether the patient had received any other vaccines within 4 weeks prior to COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the left arm on 20Mar2021(at the age of 79-years-old) at 13:45 as a single dose for COVID-19 immunisation. On 13Apr2021 at 12:00, the patient had itching, burning and stinging skin on arms, legs and back. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events itching, burning and stinging skin on arms, legs and back were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650675
Sex: M
Age:
State: UT

Vax Date: 03/30/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Acute gout on right foot, 4th toe.; The gout was accompaniedby tophi.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, two days after the second vaccine, the patient developed acute gout on right foot, 4th toe. It lasted for 2 weeks. The doctor took off indomethacin, which had not helped and put the patient on prednisone, which seemed to be helping. The gout was accompanied by tophi. At the time of report, the patient felt like the gout was moving to big toe on the same foot. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as the result of adverse events and included treatment with indomethacin, prednisone and cephalexin. The clinical outcome of the events acute gout on right foot and gout accompanied by tophi were not resolved at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650676
Sex: F
Age:
State: MO

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Hips and legs felt like they were on fire, burning; Terrible pain and agony; Feel weak; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 16Apr2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included avascular necrosis in both hips and both legs around the knees, caused from factor five and chronic pain. The patient had known allergies to bupropion hydrochloride (WELLBUTRIN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified drugs that were prescribed and over-the counter. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 18:30, the second evening after the second dose, the patient experienced hips and legs felt like they were on fire, burning, terrible pain and agony just for few hours. The patient stated that the pain slipped on after taking a nap in the early evening and the patient woke up to the terrible pain, was able to settle down and relax, and the pain was just gone. The patient still felt weak, but no more burning pain. The events did not result in doctor or other healthcare professional /clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hips and legs felt like they were on fire, burning, terrible pain and agony just for few hours and feeling weak was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Avascular necrosis (Avascular necrosis in both hips and both legs around the knees, caused from factor five.)

ID: 1650677
Sex: M
Age:
State: AZ

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: fever; Result Unstructured Data: Test Result:101.1; Comments: that lasted on and off for 2 days (more than 8 hours) that peaked at 102.7; Test Date: 20201123; Test Name: covid-19; Test Result: Positive

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: A sharp stinging headache (just like having COVID-19); Severe arm pain at injection site; Fatigue; Body aches; Hot and cold spells; A consistent fever of 101.1 that lasted on and off for 2 days (more than 8 hours) that peaked at 102.7; Face and sinus pain; Face and sinus pain; loss of taste/smell short period; loss of taste/smell short period; This is a spontaneous report from a contactable consumer (patient). A 49-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0169), via an unspecified route on 16Apr2021 at 14:30 (at the age of 49-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history included had COVID-19 on 23Nov2020, heart failure caused by COVID-19, chronic back pain due to accident that caused a Pain Pump to be administered with Bupivacaine. The patient concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8730), via an unspecified route on 26Mar2021 at 08:30 (at the age of 49-years) as dose 1, single in the left arm for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021 at 11:30, the patient experienced a sharp stinging headache (just like having COVID-19), severe arm pain at injection site, fatigue, body aches, hot and cold spells, a consistent fever of 101.1 that lasted on and off for 2 days (more than 8 hours) that peaked at 102.7, Face and sinus pain, loss of taste/smell short period. The patient did not received treatment for events. The patient underwent lab tests and procedures which included covid-19 was positive on 23Nov2020, fever was 101.1 on 16Apr2021. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650678
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Loud constant ringing in ears; A bit of vertigo; Muscles were so painful and got worse everyday; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 14Apr2021 at 11:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included interstitial cystitus, pseudo tumor cerebri, ebstein barr virus (EBV), gluten sensitivity and allergy to dairy products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included metformin hydrochloride (GLUMETZA), thyroid (ARMOUR THYROID) and alprazolam (MANUFACTURER UNKNOWN); all from an unknown date for an unspecified indication and unknown if ongoing. The patient previously received tetracycline (MANUFACTURER UNKNOWN) and sumatriptan succinate (IMITREX) from an unknown date for an unspecified indication and experienced drug allergy. On 15Apr2021 at 08:00, the patient experienced loud constant ringing in ears, a bit of vertigo, and her muscles were painful and getting worse every day. Patient stated that the ringing in ears started morning of 15Apr2021 same with the vertigo, and muscle pain was progressively getting worse. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events loud constant ringing in ears, a bit of vertigo, and muscles were painful and getting worse every day were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GLUMETZA; ARMOUR THYROID; ALPRAZOLAM

Current Illness: Dairy intolerance (Known Allergies: dairy); Gluten sensitivity (Known Allergies: gluten)

ID: 1650679
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Rash has developed primarily in torso area. I can feel it spreading to the ground and behind my ears.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 16Apr2021 at 14:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease (reported as hashimoto). The patient no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 14:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 17:00, rash had developed primarily in torso area. The patient could feel it spreading to the ground and behind her ears. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event rash had developed primarily in torso area, the patient could feel it spreading to the ground and behind her ears was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; ATORVASTATIN; ESCITALOPRAM

Current Illness:

ID: 1650680
Sex: F
Age:
State: RI

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 41-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# EW0161), at the age of 41, via an unspecified route of administration, left arm, on Apr 17, 2021, at 11:15, single dose, for COVID-19 immunisation. Medical history included genital herpes. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline for unknown indication on unknown date and unknown if ongoing. The patient has no known allergies. On Apr 18, 2021, at 08:00, patient experienced muscle pain, stiff neck, joint pain, tiredness, nausea and feeling overall unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of muscle pain, stiff neck, joint pain, tiredness, nausea and feeling overall unwell: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds: Sertraline

Current Illness:

ID: 1650681
Sex: M
Age:
State: GA

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: heart rate; Result Unstructured Data: Test Result:shooting up; Comments: 30 points of 100 - 115/my heart rate was closer to the 80's and 90's

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: headache; legs and muscles felt like under a heavy blanket and stiff; heart rate shooting up by 30 points of 100 - 115/my heart rate was closer to the 80's and 90's; this was a terrible feeling - tachycardia and there was pain in left arm with shot; this was a terrible feeling - tachycardia and there was pain in left arm with shot; this was a terrible feeling - tachycardia and there was pain in left arm with shot; This is a spontaneous report from a contactable consumer (patient) reporting for himself. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration, administered in Left arm on 16Apr2021 14:00 at the age of 56-years-old as dose 2, single for covid-19 immunisation. Medical history included thyroid issues from an unspecified date and COVID-19 on an unspecified date prior vaccination. The patient had no allergies. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: not reported) on an unspecified date as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. Facility type vaccine was other. The patient was diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. It was reported that after shot 2, on 17Apr2021, the patient experienced headache, legs and muscles felt like under a heavy blanket and stiff, and heart rate shooting up by 30 points of 100 - 115# Typically his heart rate is in the 70's so this was a terrible feeling - tachycardia and there was pain in left arm with shot, literally the next day it stopped and my heart rate was closer to the 80's and 90's, so a bit better. The patient received did not receive treatment for adverse events. Adverse events resulted in None of the above. The patient underwent lab tests and procedures which included heart rate: shooting up on 17Apr2021 (30 points of 100 - 115/my heart rate was closer to the 80's and 90's). The outcome of events was recovered on an unspecified date in 2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID

Current Illness:

ID: 1650682
Sex: F
Age:
State: NY

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Face race. Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. I believe it started within 24 hours. It has been 13 days since vaccine and the rash has not gone away; Face race. Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. I believe it started within 24 hours. It has been 13 days since vaccine and the rash has not gone away; Face race. Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. I believe it started within 24 hours. It has been 13 days since vaccine and the rash has not gone away; Face race. Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. I believe it started within 24 hours. It has been 13 days since vaccine and the rash has not gone away; Face race. Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. I believe it started within 24 hours. It has been 13 days since vaccine and the rash has not gone away; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 16:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included levothyroxine sodium (LEVOXYL) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 21:00, the patient experienced face race (coded to rash on face). Very dry skin with small raised bumps. This turned into very itchy and burning skin, particularly around eyes, temples and near jaw. The patient believed it started within 24 hours. It had been 13 days since vaccine and the rash had not gone away. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of face race; very dry skin with small raised bumps; this turned into very itchy and burning skin, particularly around eyes, temples and near jaw and included treatment with Antihistamine. The clinical outcome of the event face race; very dry skin with small raised bumps; this turned into very itchy and burning skin, particularly around eyes, temples and near jaw; the patient believed it started within 24 hours; it had been 13 days since vaccine and the rash had not gone away was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOXYL

Current Illness:

ID: 1650683
Sex: F
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Pain in right arm from shoulder to wrist; This is a spontaneous report from a contactable consumer, the patient. A 88-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 00:00 (at the age of 88-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 09Apr2021, the patient experienced pain in right arm from shoulder to wrist which was present at the time of reporting (18Apr2021). The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event pain in right arm from shoulder to wrist was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650684
Sex: M
Age:
State: MD

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Several hours after the first vaccine I became dizzy. It was not severe but it continues to this day; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Mar2021 at 11:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included A fib (Atrial fibrillation). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Mar2021, several hours after the first vaccine, the patient became dizzy. It was not severe but it continued to the day of the report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for the event. The clinical outcome of the event dizzy was not recovered, at this time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METOPROLOL

Current Illness:

ID: 1650685
Sex: F
Age:
State: ID

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Tongue sores 12 - 24 hours after vaccine; This is a spontaneous report from a contactable pharmacist, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Feb2021 at 10:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 15Mar2021 at 10:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation Medical history included allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Mar2021 the patient experienced tongue sores 12 - 24 hours after vaccine and occurred after each dose. The sores persisted intermittent for weeks following the vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the reported events. The clinical outcome of the event tongue sores was resolved with sequelae on an unknown date in 2021 at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650686
Sex: F
Age:
State: PA

Vax Date: 03/23/2021
Onset Date: 03/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Pain under left arm, arm pit area; Pain under left arm, arm pit area, that radiates towards the breast; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included shellfish allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC) taken for unspecified indication from an unknown date. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 01Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 28Mar2021 at 15:00, the patient experienced pain under left arm that radiated towards the breast. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain under left arm that radiated towards the breast was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1650687
Sex: F
Age:
State: OK

Vax Date: 03/20/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: I have sores in my mouth; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 20Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, high blood pressure and COVID-19 (Prior to vaccination the patient was diagnosed with COVID-19). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6202) via an unspecified route of administration in the left arm on 27Feb2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 01Apr2021 at 00:00, after one week of vaccination, the patient experienced sores in mouth, they are all along the right side of the mouth. They were getting worse after three weeks, the patient had been to the doctor two times already and was about to visit again. The first time they gave anti-virus drug and the second time steroids and they are still bad and painful in my mouth. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported event which included treatment with anti-virus drug and steroids. The clinical outcome of the event sores in mouth was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650688
Sex: F
Age:
State: PA

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5; Comments: fever of 99.8 which then rose to 100.5; Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:99.8; Comments: fever of 99.8 which then rose to 100.5

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Fever; Headache; Body aches; Joint pain; Fatigue and tiredness; Chills; Swollen lymph nodes in neck; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 11Apr2021 at 12:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included lipedema (connective tissue/fat disorder) and COVID-19 on an unknown date. The patient was allergic to sulfa drugs. The patient did not receive any medication within two weeks of vaccination. The patient previously took sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 06:30, the patient experienced fever 99.8 which then rose to 100.5, headache, body aches, joint pain, fatigue and tiredness, chills and swollen lymph nodes in neck. Therapeutic measures were taken as a result of the events and included treatment with extra-strength acetaminophen. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever was resolved on 14Apr2021; swollen lymph nodes, chills, body ache and joint pain were resolved on 17Apr2021 and headache and fatigue were resolved on 18Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650689
Sex: F
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Clumps of vaginal blood 3 days after vaccinations; This is a spontaneous report from a contactable consumer (patient). A 31-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Right on 18Mar2021 as dose 1, single; dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 16:00 (Lot number: EW0161) as dose 2, single (both doses at the age of 31-year-old) for covid-19 immunization. Medical history was reported as none. Known allergies were reported as no. The patient concomitant medications were not reported. Patient did not receive other medications in two weeks. Patient did not have covid-19 prior vaccination and covid-19 was not tested post vaccination. On 04Apr2021 at 20:00, the patient experienced clumps of vaginal blood 3 days after vaccinations. Patient stated she had mirena iud and had not menstruated in 4 years. Patient did not receive any treatment for adverse event. The outcome of event was recovering. No follow-up attempts are possible. No further information is expected. Follow-up (19Jul2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1650690
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Extreme tiredness throughout the body; Throbbing pain on the side of head and behind eyes; Lightheadedness; Cough; Occasional sneeze; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, the patient experienced extreme tiredness throughout the body, throbbing pain on the side of the head and behind eyes, lightheadedness, cough and the occasional sneeze. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events extreme tiredness throughout the body, throbbing pain on the side of the head and behind eyes, lightheadedness, cough and occasional sneeze was resolving at the time of the report. No follow-up attempts are possible; information about lot/ batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650691
Sex: M
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210418; Test Name: Heartbeat; Result Unstructured Data: Test Result:Pounding rapid irregular; Comments: at 09:00

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Intensifying Nausea; Pounding rapid irregular heartbeat; Pounding rapid irregular heartbeat; Hot flashes; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 16Apr2021 at 10:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 26Mar2021 at 10:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 09:00 (also reported as approximately 48 hours post-vaccination), the patient experienced intensifying nausea, pounding rapid irregular heartbeat, hot flashes, and malaise lasting for 6 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of event malaise was recovered on 18Apr2021 at 15:00. The clinical outcome of the events intensifying nausea, pounding rapid irregular heartbeat and hot flashes were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650692
Sex: F
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: I experienced presyncope at around 6:30am today after receiving the second dose; Sudden ringing in ears; Profuse sweating; Tingling hands; Headache; Low fever; Chills; Body aches; I had slept poorly due to vaccine side effects,; I'd had heart palpitations much of the night after receiving the second dose,; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7533) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 at 08:00 as a single dose for COVID-19 immunisation. Previously she also took amoxicillin (MANUFACTURER UNKNOWN) and thiomersal (THIMEROSAL) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 14Apr2021, the patient had heart palpitations much of the night after receiving the second dose, along with the other side effects low fever, chills, body aches, and headaches. The patient had slept poorly due to vaccine side effects, and had gotten out of bed early morning to take some paracetamol (TYLENOL) for headache. On 15Apr2021 at 06:30, the patient experienced presyncope, sudden ringing in ears, profuse sweating and tingling hands. The patient did not pass out but felt like it came close. The patient took paracetamol (TYLENOL), while this was happening, and within a few minutes the presyncope episode passed. The patient felt much better after taking the paracetamol (TYLENOL) and sleeping for a few hours. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event except headache. Therapeutic measures were taken as a result of headache which included treatment with paracetamol (TYLENOL). The clinical outcomes of the events heart palpitations, headache, low fever, chills, body aches, presyncope, sudden ringing in ears, profuse sweating, had slept poorly, tingling hands were recovered on 15Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650693
Sex: F
Age:
State:

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: This is a spontaneous report from a noncontactable consumer. A 41-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 41, via an unspecified route of administration, right arm, on Apr 11, 2021, at 14:45, single dose, for COVID-19 immunisation. Medical history included migraine headache. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medication included Excedrin (acetylsalicylic acid/caffeine/paracetamol) taken for unknown indication from unknown date. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 41, via an unspecified route of administration, right arm, on Mar 21, 2021, at 14:45, single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 12, 2021, at 01:00, patient experienced migraine headaches and was unable to sleep. No therapeutic measures taken as result of adverse events. Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of migraine headaches and unable to sleep was resolving. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds: Excedrin (acetylsalicylic acid/caffeine/paracetamol)

Current Illness:

ID: 1650694
Sex: F
Age:
State: VT

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fatigue; This is a spontaneous report from a non-contactable pharmacist. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and nortriptyline (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. The patient had no known drug allergies (NKDA). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced fatigue. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event fatigue was recovered on an unknown date in Apr2021. No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: GABAPENTIN; NORTRIPTYLINE

Current Illness:

ID: 1650695
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: whole body was aching; Sweating; Chills; I felt I had shutter glass all over my body; Strong headache/ headache that did not respond to any medication; Unable to concentrate, focus; Left under arm lymph node very swelled for over 10 days.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included graves. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 03:00, 16 hours after getting the second shot, the patient experienced whole body aching, sweating, chills and felt like the patient had shutter glass all over the body. These symptoms lasted for 4 days. The patient had a strong headache that last for 9 days, unable to concentrate, focus and a headache that did not respond to any medication and left under arm lymph node very swollen for over 10 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the event headache and included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aching, sweating, chills and felt like had shutter glass all over the body was recovered on 05Apr2021, strong headache that did not respond to any medication was recovered on 10Apr2021, left under arm lymph node very swollen was recovered on 11Apr2021 and the outcome of unable to concentrate, focus was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650696
Sex: F
Age:
State: OR

Vax Date: 04/07/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Weird symmetrical pattern of wine-colored spots around vaccination site. No pain, no itching, flat, smooth surface.; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 15:45(at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included thrombosis leg and had mild allergy to some food products. Concomitant medications were not reported. The patient had mildly known allergy to some food products Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient experienced weird symmetrical pattern of wine colored spots around vaccination site. No pain, no itching, flat, smooth surface. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit, Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the event weird symmetrical pattern of wine-colored spots around vaccination site was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650697
Sex: F
Age:
State: TX

Vax Date: 02/22/2021
Onset Date: 03/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210317; Test Name: estrogen; Result Unstructured Data: Test Result:increased; Test Date: 20210317; Test Name: prolactin; Result Unstructured Data: Test Result:increased

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Prolactin increased; Estrogen increased; This is a spontaneous report from a contactable physician, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 22Feb2021 at 18:00 (at the age of 34-years-old) as a single dose for COVID-19immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient had her prolactin and estrogen increased and reported that her previous levels were normal. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events prolactin increased and estrogen increased were unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650698
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Severe pain associated with periods; cramping; nausea; Unable to walk due to pain; Unable to walk due to pain or perform any daily tasks; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15(at the age of 30-year-old) as a single dose for COVID-19 immunisation. The medical history of the patient included endometriosis. The concomitant medications of the patient was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 14:00, 3 days after vaccination, the patient experienced severe pain associated with periods, cramping, nausea, unable to walk due to pain or perform any daily tasks. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe pain associated with periods, cramping, nausea and unable to walk was not recovered at the time of report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650699
Sex: F
Age:
State: NJ

Vax Date: 04/06/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Chills; Headache; Body aches; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 11:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and supraventricular tachycardia (SVT). The patient had no allergies to food, medications or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN) both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 11:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 14:00 the patient experienced chills, headache, body aches and exhaustion. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, headache, body aches and exhaustion were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; METOPROLOL

Current Illness:

ID: 1650700
Sex: F
Age:
State: MA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies: Aspirin and Tussionex

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 40-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP6955), at the age of 40, via an unspecified route of administration, left arm, on Apr 13, 2021, at 09:15, single dose, for COVID-19 immunisation. Medical history included asthma. Concomitant medications included Albuterol (salbutamol) for unknown indication from unknown date and unknown if ongoing. The patient previously received Aspirin and Tussionex for unknown indications and experienced drug allergy. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, patient experienced arm soreness, brain fog, muscle aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of the arm soreness, brain fog, muscle aches and fatigue included treatment with Tylenol. The outcome of arm soreness, brain fog, muscle aches and fatigue: recovering (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds: Albuterol (salbutamol)

Current Illness:

ID: 1650701
Sex: U
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore throat; Headache; Hot flashes; Muscle aches; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old patient of an unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EVE 0153) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, and blood pressure high. Patient had no known allergies. Patient did not receive other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 14:30, the patient experienced sore throat, headache, hot flashes, muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore throat, headache, hot flashes, muscle aches was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650702
Sex: F
Age:
State: IN

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Swollen lymph nodes under right arm; Hives; Headache; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021, the patient experienced swollen lymph nodes under right arm, hives, headache, chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event swollen lymph nodes under right arm, hives, headache, chills and fatigue was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650703
Sex: M
Age:
State: OH

Vax Date: 04/15/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210301; Test Name: antibodies; Test Result: Negative ; Test Name: X-ray; Result Unstructured Data: Test Result:pneumonia

Allergies:

Symptom List: Injection site pain

Symptoms: stiff neck and knotted muscles happened only this time in the right side of his neck; Everything was sore, neck; spaciness; Everything was sore; right shoulder did get sore right away eventually; Slight fever/ slight elevated temperature; reinvigorated left shoulder injection site soreness; felt like someone beat him with a baseball bat; almost like he couldn't move; muscular soreness; hard for him to move; slight bulbiness across the whole right injection site, underneath, no external view; feels a little fluish, like he is coming down with something/ feeling like he can't get off the couch; His O2 saturations were a little higher than normal; He had soreness especially neck and arms; This is a spontaneous report from a contactable consumer (patient). A 61-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EW0151; Expiration Date: 30Jul2021; NDC number: unknown) via an unspecified route of administration on 15Apr2021 at 10:00 (at the age of 61-years-old) in right arm as a single dose for covid-19 immunization. Medical history including any illness at time of vaccination) included migraines (he had history of migraines and his mother had a history of it as well), reactive airways disease, occasionally high iron, erratic heartbeat about 5 years ago. He mentioned he had to wear a Holter monitor and wore for 24hrs and one 48hrs. The 24hr got 200 events and the 48 half of those in 48hrs. He was on beta-blockers for a while. He has a history of leaky gut type syndrome and he and his wife had been eating organically and staying away from processed food; taking supplements which had to do with anti-clotting and blood thinning attributes like fish oil and turmeric. He does take an 81 mg aspirin from time to time and has taken 2 in the last couple of days. He does not normally take them that often. His blood clotting factors is probably suppressed more than the average citizen. He stated that clinic found hole between his two heart chambers that he had probably since birth. Caller stated that 5 years ago he had sudden onset heart palpitations, and he still gets a flutter once in a while, but it had subsided and cannot determine where it came from. Just prior to covid starting in August he was cutting grass and ran across possible mold in grass. He coughed for like three days. His sinuses got infected, went down in his lungs and was treated with antibiotics for 3-5 rounds. He was on Doxycycline and something else that was not clearly stated and not clarified further. This generated a presumed pneumonia confirmed by x-ray. After treated with antibiotics it was probably when pneumonia went away. However, he had problem that continued all the way through January. He was coughing a lot. He passed out on the floor and could not breathe. His oxygen sets dropped to 80's so coughing for hours at a time; multiple hospitals to culture and came with two different kinds of molds non-human pathogens, things started getting better, February went to reactive airway disease, lungs overreact. He had been to the ER twice with eye issues. He had German measles, bronchial hyperreactivity, occasionally high iron, erratic heartbeat in past. Family medical history relevant to adverse event included cancer on dad's side of the family. Concomitant medications included doxycycline (DOXYCLINE [DOXYCYCLINE]) taken for an unspecified indication, start and stop date were not reported; ibuprofen (IBUPROFEN) taken for migraine, start and stop date were not reported. He had not taken it often within the last year. He may had taken two doses of the 200mg within a year. Trying to stop due to stomach issues. Caller does mention that a couple of hours before both doses of the Pfizer covid-19 vaccine he took half of a pill of over the counter generic 12-hour Claritin. The patient's historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine) on 25Mar2021 at 10:00 in left arm for covid-19 immunization. Caller stated within seconds, instantaneously, he felt it shoot up his neck on the left side and his muscles knotted, which caused him to have a stiff neck. It stayed that way, like if you sleep on your neck wrong all night. It was not the MRNA he had a problem with, but the carrier components he felt immediately reacting to. On the date he goes for vccination he had an O2 sensor on and within ten minutes he felt mild spacy and lightheaded, kind of dizziness. Then he was ok the next day. Then on the third day the mild spacy, dizziness, listlessness came back slightly, then that was it. Confirmed the spaciness and listlessness went hand in hand. Caller stated he recovered fully from all the events of first shot by 29Mar2021. Caller does state that he had O2 sensor on him at the time of immunization and his O2 levels stayed normal. Caller stated that his wife had to drive them home after the first dose because he felt a little fist bolding, like not seeing quite exact, spacy kind of like, something foreign feeling. Caller stated that prior to getting the first shot he was fairly active and attributed these events to that and kind of dismissed them because thought over did something. He does have pre-covid lung issue. Caller mentioned in Sep2019 or Oct2019 when he had X-Ray that showed Pneumonia, it was all concluded by Jan2020 somewhere around there. His local doctor placed him on generic singular a small dose. He weaned off quickly, it cured him within a week in regard to hacking, wheezing, bronchial issues. There were so many FDA warnings and things. Caller received second dose of Pfizer covid-19 vaccine on 15Apr2021 at 10:00 in his right arm, his reaction was little more delayed than the first dose. Caller stated within 20 min exactly the same stiff neck and knotted muscles happened only this time in the right side of his neck. Caller does note that there was no spaciness right away with the second dose. His O2 saturations were a little higher than normal. He stated that him and his wife were stuck around for an hour monitoring everything before he left the shot facility. He felt ok and at the time he thought he would drive but went ahead and let his wife drive home. Right about 5 hours later he started experiencing the spaciness like before with the first shot, but at 7 hours after getting the shot he felt like someone beat him with a baseball bat. Everything was sore, especially neck and arms. Both times his shoulder did not get sore right away, but last night his right shoulder did get sore right away eventually. It was hard for him to move. He also reported that where he got the injection there was slight bulbiness, it was swollen slightly. Just a little bit puffy like in the muscle. The event did not require emergency room and physician office visit. He confirmed he had no chills, but he had slight elevated temperature in morning, may had been up 1 degree from normal and his normal is 1 degree below normal, so maybe up to 99 or 100 and dropped off pretty quick. He ate normal breakfast and things like that and moving around more and thought he got a good wind, but then got listless in afternoon while he was waiting on hold for the call, he got feeling like he can't get off the couch. He felt a little better later. He had a feeling that tomorrow may be pretty ok. He felt little flui-sh, like a light flue, like he's coming down with something today. He stated it was like the dose he got reinvigorated left shoulder injection site soreness from the first dose. He can't remember being hardly sore on the left side after the first dose. He thinks maybe it started on the third day. It was worse on his first shot site after his second shot like a residual effect. Caller also adds that him or his wife didn't drink four days after the first dose of Pfizer covid-19 vaccine and for the second one didn't drink any alcohol four days before or four days after the shot. He got the shot due to pre-existing possibilities; if he got covid he may not fair well. Caller stated he had heard stories that the vaccine was not affective against the south African variant but everything on TV says that i

Other Meds: DOXYCLINE [DOXYCYCLINE]; IBUPROFEN

Current Illness:

ID: 1650704
Sex: F
Age:
State: NE

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Vomiting 3 times in the span of 3 hours; Low grade fever; inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO161) via an unspecified route of administration in the right arm on 14Apr2021 at 09:30(at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included progressive neurodegenerative disorder, primary progressive aphasia. The patient had no known allergies to food, medication or other products. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 29Mar2021 at 12:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 17:00, the patient experienced vomiting 3 times in the span of 3 hours and low-grade fever. The clinical outcome of the event low grade fever and vomiting was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650705
Sex: F
Age:
State: OH

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: 14 hours after got chilled to the bones& lasted about 4 hours, had on clothes & a hoodie & 2 blankets.; Also had a headache which lasted about 24 hours; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: cw0151) via an unspecified route of administration in the left arm on 13Apr2021 at 18:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, hyperthyroidism, sulfonamide allergy (Bactrum allergy). Concomitant medications included levothyroxine sodium (SYNTHROID), sertraline hydrochloride (ZOLOFT), meloxicam (MOBIC), losartan potassium (COZAAR), molixcan (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6206) via an unspecified route of administration in the left arm on 18Mar2021 at 19:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 10:00, the patient experienced chilled to the bones and lasted about 4 hours, had on clothes and a hoodie and 2 blankets. Also had a headache which lasted about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events chilled to the bones, headache was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; ZOLOFT; MOBIC; COZAAR

Current Illness: Sulfonamide allergy (Known Allergies: bactrum)

ID: 1650706
Sex: M
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Penicillin allergy

Symptom List: Tremor

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), at the age of 39, via an unspecified route of administration, on an unknown date, in Apr 2021, at 10:00, single dose, for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Singulair (montelukast sodium), from unknown date for unknown indication and unknown if ongoing. On an unknown date in Apr 2021, at 19:00 (about 8 hours after first injection), patient was a little nauseous and arm was sore for most of the day. No therapeutic measures taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of nausea and sore arm recovered on an unknown date in Apr 2021. No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds: Singulair

Current Illness:

ID: 1650707
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Numbness from the left hip to the left leg.; I have a severe pain; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 43 years), dose 1 via an unspecified route of administration, administered in Arm Left on 09Apr2021 16:45 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included astemizole (TYRENOL) within 2 weeks of vaccination. The patient reported severe pain and numbness from the left hip to the left leg on 11Apr2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the event. Ovid has not been tested prior to or post vaccination. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: TYRENOL

Current Illness:

ID: 1650708
Sex: M
Age:
State: UT

Vax Date: 03/25/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210401; Test Name: Blood pressure; Result Unstructured Data: Test Result:dangerous elevation; Test Date: 20210410; Test Name: Blood test; Test Result: Negative ; Test Date: 20210401; Test Name: weight; Result Unstructured Data: Test Result:drastic weight loss

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: major illness set in starting with flu symptoms; major illness set in starting with flu symptoms; severe distress; fever; chills; body pain; dangerous elevation Blood Pressure; drastic weight loss; Still sick; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EN6206) via an unspecified route of administration (Age at vaccination 55-year) in Left Arm on 25Mar2021 as dose 2, single for COVID-19 immunization. Medical history included Chronic pain, liver cirrhosis, low oxygen, all from an unknown date and unknown if ongoing. Concomitant medications included morphine; gabapentin; fluoxetine hydrochloride (PROZAC); tamsulosin hydrochloride (FLOWMAX); all taken for an unspecified indication, start and stop date were not reported. Historical Vaccine includes first dose of BNT162B2 (Lot Number: EN6206) administered in left arm on 04Apr2021 at 11:45 AM for COVID-19 immunization; First shot minor issues. No known allergies were reported. No COVID prior vaccination was reported. The patient tested COVID post vaccination. The patient received no other vaccine in fourweeks. On 01Apr2021 at 07:30 PM the patient experienced major illness set in starting with flu symptoms, Ended up with severe distress, fever, chills, body pain, dangerous elevation Blood Pressure, two ER visits, drastic weight loss. Worst parts of the Bible. Still sick but not as severe. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: dangerous elevation on 01Apr2021, blood test for COVID: negative on 10Apr2021, weight: drastic weight loss on 01Apr2021. Therapeutic measures were taken as a result of the adverse events; treatment received with Fluid, migraine meds, CT scan, x-ray, antibiotics. The clinical outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: MORPHINE; GABAPENTIN; PROZAC; FLOWMAX

Current Illness:

ID: 1650709
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER2613), at the age of 43, via an unspecified route of administration, left arm, on Mar 31, 2021, at 09:30, single dose, for COVID-19 immunisation. Medical history: none. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 31, 2021, at 10:30, patient experienced nausea, chills, low fever and fatigue for 72 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures not taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of nausea, chills, low fever and fatigue resolved on Apr 3, 2021 (after the duration of 72 hours). No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1650710
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Experience tired/achy and postnasal drip; Experience tired/achy and postnasal drip; Experience tired/achy and postnasal drip; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 the patient experienced tired/achy and postnasal drip. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events experienced tired/achy and postnasal drip was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650711
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Left deltoid soreness, mild to moderate, resolving with exercise; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 428068) via an unspecified route of administration in the arm left on 14Apr2021 at 13:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 16:00, the patient experienced Left deltoid soreness, mild to moderate, resolving with exercise. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event left deltoid soreness, mild to moderate, resolving with exercise was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650712
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 03/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Shortness of breath since first vaccine; This is a spontaneous report from a contactable consumer (patient). A 39-years-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date of 2021 as dose 1, single (at the age of 39-years-old) for COVID-19 immunisation. Medical history included Magnetic Resonance Imaging (MRI) dye allergy from an unknown date and unknown if ongoing. Patient had no other vaccine in four weeks. Patient had no other medications/ concomitant medications in two weeks. Patient was not diagnosed with COVID-19 prior to vaccination and on an unspecified date of 2021, patient had been tested for COVID-19, post vaccination, by nasal swab test and result was negative. On 18Mar2021, patient experienced shortness of breath since first vaccine. Patient had doctor or other healthcare professional office/clinic and emergency room/department or urgent care visit for the event. Therapeutic measures were taken as a result of shortness of breath since first vaccine and treatment included steroid. The outcome of the event was not recovered. No follow up attempts are possible; Information about lot/batch number cannot be requested. No further information is expected.

Other Meds:

Current Illness:

ID: 1650713
Sex: F
Age:
State:

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Latex; Celexa (citalopram hydrobromide)

Symptom List: Pain in extremity

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 39, via an unspecified route of administration, left arm, on Apr 8, 2021, at 15:00, single dose, for COVID-19 immunisation. Medical history included latex allergy. The patient previously received Celexa (citalopram hydrobromide), for an unknown indication from an unspecified date; and experienced drug allergy. Concomitant medications not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP7534) via an unspecified route of administration, left arm, on Mar 17, 2021, at 11:30, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 9, 2021, at 04:00, patient experienced flu-like symptoms (nausea; headaches; fatigue) 12 hours after the shot, which lasted 4 days. The fatigue lasted 7 days after shot. No therapeutic measures taken as a result of reported events. The outcome of flu-like symptoms 12 hours after shot (nausea and headaches) recovered on Apr 12, 2021; while fatigue: recovering (at the time of this report). No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1650714
Sex: F
Age:
State: IN

Vax Date:
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Stuffy nose; Sore throat; Headache; Elevated temperature; Injection site was sore; Neck was stiff; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN)via an unspecified route of administration on an unknown date(at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, generalized anxiety disorder(GAD), conversion disorder, 4 concussion, hypermobility and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN) , fluoxetine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and omeprazole magnesium (OMEPRAL); all from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced injection site was sore, neck was stiff and dizziness. On 15Apr2021, the patient experienced stuffy nose, sore throat, headache and elevated temperature. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site was sore, neck was stiff dizziness, stuffy nose, sore throat, headache and elevated temperature were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds: BUSPIRONE; FLUOXETINE; BUPROPION; OMEPRAL [OMEPRAZOLE MAGNESIUM]

Current Illness:

ID: 1650715
Sex: M
Age:
State: PA

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210418; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: diagnosed as migraine; Unable to work; Severe headache; Nausea; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 10:45 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and metoprolol succinate (TOPROL XL); both for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 06:00, next day to vaccination, severe headache started with nausea and lightheadedness. By 16Apr2021, patient was unable to work. The patient went to ER and was diagnosed as having migraine and had no blood work or tests done. The patient stated he would see family physician the day after. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab for COVID-19 on 18Apr2021 and the result was pending at the time of this report. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as result of events severe headache, nausea, lightheadedness and migraine and included treatment with intravenous fluids (IV fluids) and migraine cocktail - Toradol. The clinical outcome of the events severe headache with nausea and lightheadedness which was diagnosed as migraine and unable to work was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; TOPROL XL

Current Illness:

ID: 1650716
Sex: F
Age:
State: VA

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Chronic hives due to vaccination; Comments: Allergy blood testing

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Hives/Chronic hives; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the right arm on 28Jan2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK4176) via an unspecified route of administration in the left arm on 06Jan2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 29Jan2021, the patient reported that she has had hives since the day after the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had been to the allergist and was awaiting a dermatologist appointment. On an unknown date, the patient underwent an allergy blood testing and the allergist diagnosed the patient with chronic hives due to the vaccination. Therapeutic measures were taken as a result of events and included treatment with prednisone (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN), and cetirizine hydrochloride (ZYRTEC). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives/chronic hives was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650717
Sex: F
Age:
State: OH

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Started feeling bad; Unable to function; Double vision; Memory loss; confused; Headaches; chills; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration on 08Apr2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Patient had unspecified medical history. Patient had no known allergies. The patient received other medications within two weeks of vaccination, names were unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced started feeling bad, had memory loss, was confused, unable to function. Headaches, double vision, chills. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events started feeling bad, had memory loss, was confused, unable to function. Headaches, double vision, chills was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650718
Sex: F
Age:
State: MD

Vax Date: 03/29/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: swollen glands under arm on left side; rash with itching; burning; pimples; This is a spontaneous report from a contactable pharmacist. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via intramuscular route of administration in the right arm on 29Mar2021 at 09:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, hyperlipidaemia, prediabetes, hypertension and hypothyroidism. The patient's allergies to medications, food, or other products were reported as not applicable. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID) and MVI; for unknown indications from unknown start dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced swollen glands under arm on left side, rash with itching, burning, pimples which developed 3-4 days post first dose of vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events included treatment with valacyclovir (MANUFACTURER UNKNOWN). The clinical outcome of the events swollen glands under arm on left, rash with itching, burning and pimples were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE; ROSUVASTATIN; SYNTHROID

Current Illness:

ID: 1650719
Sex: F
Age:
State:

Vax Date: 03/27/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: experienced a change in menstrual cycle; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received an unknown dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 27Mar2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease. The patient had allergy to contrast iodine dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date in 2021, following the vaccine, the patient experienced a change in menstrual cycle. It came 1.5 week earlier than planned in tracking device and with various different symptoms. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event of change in menstrual cycle was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650720
Sex: F
Age:
State: NY

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: tingling in tongue and gums; headache; arm pain; This is a spontaneous report from a contactable nurse, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to figs. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), topiramate (TOPAMAX), levonorgestrel (MIRENA), ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN); all from unknown date for an unspecified indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation and took erythromycin (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced tingling in tongue and gums about 45 minutes after receiving the injection, which resolved after about two hours without intervention and had a headache starting few hours after the injection and arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, patient had not been tested for COVID-19. The clinical outcome of the event tingling in tongue and gums was recovered on 08Apr2021 and of the headache was recovered on 11Apr2021 and of the arm pain was recovered on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; TOPAMAX; MIRENA; VITAMIN C [ASCORBIC ACID]; VITAMIN D NOS

Current Illness:

ID: 1650721
Sex: M
Age:
State: IA

Vax Date: 03/27/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Tinnitus- increase in severity; Impacted ability to sleep; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 14:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included tinnitus and COVID-19. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient had increase in severity of tinnitus which caused patient to wake up at night and kept the patient from falling asleep, the patient had issues in the past but it never impacted the patient's ability to sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events increase in severity of tinnitus and impacted ability to sleep were not resolved at the time of the report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 1650722
Sex: M
Age:
State: KS

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Felt like had the flu the next day; Body aches; Slightly nauseated; Severe chills; Felt like burning up; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included cystitis interstitial and nasal infection; both from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to food, medications, or other products. Concomitant medications included doxycycline (MANUFACTURER UNKNOWN) from unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 23:00, that night, the patient had severe chills for 3 hours, then felt like he was burning up. On 15Apr2021, the next day, the patient felt like he had the flu, body aches, slightly nauseated (but no fever). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe chills was recovered on 15Apr2021 and of the events felt like he was burning, felt like he had the flu, body aches and slightly nauseated was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: DOXYCYCLINE

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am